Mitoribosome protein translation signaling and survival mechanisms

线粒体核糖体蛋白翻译信号传导和生存机制

基本信息

  • 批准号:
    10714636
  • 负责人:
  • 金额:
    $ 72.73万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-30 至 2028-05-31
  • 项目状态:
    未结题

项目摘要

Abstract Defective mitochondrial function causes cellular damage and death under stress conditions. At the organismal level mitochondrial dysfunction occurs in mitochondrial diseases caused by genetic mutations, neurodegeneration, and with less severity during aging, damaging vulnerable tissues such as brain and skeletal muscle. Mitochondrial mutations cause failures that disrupt energy metabolism, including reductive/oxidative imbalances and inflammation that lead to tissue damage and eventually death. Mitochondrial defective cells depend on glycolysis for energy generation and, similar to mitochondrial disease patients, are vulnerable to stress conditions. The mechanisms that cause this cell damage and how mitochondrial defective cells can be protected against damage and death are largely unknown. This is important because there are no cures for mitochondrial diseases, and dysfunctional mitochondria is one of the hallmarks of aging or neurodegeneration. In genetic and chemical high throughput screens our laboratory has identified a subset of antibiotics, including tetracyclines, that target the mitoribosome protein translation, and rescue cell death and inflammation in cellular and mouse models of mitochondrial diseases. Tetracyclines-promoted cell survival depends on suppression of ER stress and Unfolded Protein Response (UPR) that is independent of the transcription factor ATF4. The mechanisms of how tetracycline-induced mitoribosome stalling/splitting protect against cell death in cellular and mouse pre-clinical models of mitochondrial diseases is unknown. We hypothesize that a signaling mechanism initiated at the stalled/split mitoribosome promotes cell survival in the context of mitochondrial defective cells and human disease mutations. The main goal of this application is to identify the signaling and cellular mechanisms caused by stalled and split mitoribosomes that promote cell survival and determine the efficacy in cellular and mouse models of mitochondrial diseases. We propose 1) to determine the initial signaling mechanism at the partial stalled/split mitoribosome that promotes survival in mitochondrial disease mutant cells, focusing on MALSU splitting factor and additional proteins associated at the mitoribosome; 2) to analyze the components downstream of the stalled/split mitoribosome that promote survival in mitochondrial disease mutant cells, focusing on components that link the stalled/split mitoribosome to ER stress IRE1a and UPR responses and 3) to analyze the effects of tetracycline analogs in Ndufs4 KO mice, a mitochondrial complex I deficient mouse model, focusing on the effects tetracyclines on fitness, survival and modulation of mitoribosome signaling/ER stress and suppression of brain and skeletal muscle immune inflammation in Ndufs4 KO mice. The outcomes of this application will determine the regulatory and signaling mechanisms that are initiated by the stalled/split mitoribosome in conditions of defective mitochondrial disease mutations. These mechanisms will advance our understanding of mitoribosome protein translation and signaling mechanisms that protect cell damage in the context of mitochondrial dysregulation and diseases.
摘要 线粒体功能缺陷导致细胞在应激条件下损伤和死亡。在Organismal 线粒体水平功能障碍发生在由基因突变引起的线粒体疾病中, 神经退行性变,并且在衰老期间严重程度较低,损害脆弱组织,如大脑和骨骼 肌肉.线粒体突变导致破坏能量代谢的失败,包括还原/氧化 失衡和炎症导致组织损伤并最终死亡。线粒体缺陷细胞 依赖糖酵解产生能量,与线粒体疾病患者相似, 压力条件。导致这种细胞损伤的机制以及线粒体缺陷细胞如何被 保护免受损害和死亡的情况在很大程度上是未知的。这很重要,因为没有治愈方法 线粒体疾病和功能障碍的线粒体是衰老或神经变性的标志之一。 在遗传和化学高通量筛选中,我们的实验室已经确定了抗生素的一个子集,包括 四环素类,靶向线粒体蛋白翻译,并在细胞内拯救细胞死亡和炎症 和线粒体疾病的小鼠模型。四环素促进的细胞存活依赖于抑制 内质网应激和未折叠蛋白反应(UPR)是独立的转录因子ATF 4。的 四环素诱导的有丝分裂体停滞/分裂如何保护细胞免受细胞死亡, 线粒体疾病的小鼠临床前模型是未知的。我们假设一种信号机制 在线粒体缺陷细胞的情况下,在停滞/分裂的线粒体体处起始的蛋白质促进细胞存活, 人类疾病突变。这个应用程序的主要目标是识别信号和细胞 由停滞和分裂的线粒体引起的机制,促进细胞存活并决定细胞的增殖。 在线粒体疾病的细胞和小鼠模型中的功效。我们建议:(1)确定初始 部分停滞/分裂线粒体的信号传导机制促进线粒体疾病中的存活 突变细胞,重点是MALSU分裂因子和其他与线粒体相关的蛋白质; 2) 分析停滞/分裂的线粒体的下游组分,其促进线粒体中的存活, 疾病突变细胞,重点是将停滞/分裂的线粒体与ER应激IRE 1a联系起来的组分, UPR反应和3)分析四环素类似物在Ndufs 4 KO小鼠(线粒体复合物)中的作用 I缺陷小鼠模型,重点是四环素类药物对健康,存活和线粒体调节的影响 在Ndufs 4 KO小鼠中的信号传导/ER应激和脑和骨骼肌免疫炎症的抑制。的 本申请的结果将决定由基因启动的调节和信号传导机制。 在有缺陷的线粒体疾病突变的条件下停滞/分裂的线粒体。这些机制将 促进我们对保护细胞的线粒体蛋白质翻译和信号机制的理解 在线粒体失调和疾病的背景下的损害。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pere Puigserver其他文献

Pere Puigserver的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pere Puigserver', 18)}}的其他基金

Regulatory mechanisms of mitochondrial cristae biogenesis and thermogenic function
线粒体嵴生物发生和产热功能的调节机制
  • 批准号:
    10716595
  • 财政年份:
    2023
  • 资助金额:
    $ 72.73万
  • 项目类别:
Mitochondrial Protein Translation Signaling and Survival Mechanisms
线粒体蛋白翻译信号和生存机制
  • 批准号:
    10462235
  • 财政年份:
    2021
  • 资助金额:
    $ 72.73万
  • 项目类别:
Metabolic and Bioenergetic Control in Mitochondrial Diseases
线粒体疾病的代谢和生物能控制
  • 批准号:
    9926273
  • 财政年份:
    2017
  • 资助金额:
    $ 72.73万
  • 项目类别:
Metabolic and epigenetic dependencies in melanomas during metastasis and targeted-drug resistance
黑色素瘤转移和靶向药物耐药过程中的代谢和表观遗传依赖性
  • 批准号:
    10599853
  • 财政年份:
    2014
  • 资助金额:
    $ 72.73万
  • 项目类别:
Metabolic Vulnerabilities in Melanoma Tumors
黑色素瘤的代谢脆弱性
  • 批准号:
    8760634
  • 财政年份:
    2014
  • 资助金额:
    $ 72.73万
  • 项目类别:
Metabolic and epigenetic dependencies in melanomas during metastasis and targeted-drug resistance
黑色素瘤转移和靶向药物耐药过程中的代谢和表观遗传依赖性
  • 批准号:
    10369725
  • 财政年份:
    2014
  • 资助金额:
    $ 72.73万
  • 项目类别:
Energy Expenditure and Metabolic Effects through Brown/Beige Adipose Clk2 Kinase
棕色/米色脂肪 Clk2 激酶的能量消耗和代谢效应
  • 批准号:
    9902407
  • 财政年份:
    2011
  • 资助金额:
    $ 72.73万
  • 项目类别:
Insulin Signaling and Metabolic Effects through CLK2 Kinase
CLK2 激酶的胰岛素信号传导和代谢效应
  • 批准号:
    8638955
  • 财政年份:
    2011
  • 资助金额:
    $ 72.73万
  • 项目类别:
Insulin Signaling and Metabolic Effects through CLK2 Kinase
CLK2 激酶的胰岛素信号传导和代谢效应
  • 批准号:
    8448785
  • 财政年份:
    2011
  • 资助金额:
    $ 72.73万
  • 项目类别:
Insulin Signaling and Metabolic Effects through CLK2 Kinase
CLK2 激酶的胰岛素信号传导和代谢效应
  • 批准号:
    8242706
  • 财政年份:
    2011
  • 资助金额:
    $ 72.73万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 72.73万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 72.73万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 72.73万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 72.73万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 72.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 72.73万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 72.73万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 72.73万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 72.73万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 72.73万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了